Human ILF3 ELISA Kit

Alternative name
Human Double-stranded RNA-binding protein 76 ELISA Kit;Human DRBP76 ELISA Kit;Human M-phase phosphoprotein 4 ELISA Kit;Human MPP4 ELISA Kit;Human nuclear factor associated with dsRNA ELISA Kit;Human NFAR ELISA Kit;Human nuclear factor of activated T-cells 90 kDa ELISA Kit;Human NF-AT-90 ELISA Kit;Human translational control protein 80 ELISA Kit;Human TCP80 ELISA Kit;Human DRBF ELISA Kit;Human MPHOSPH4 ELISA Kit;Human NF90 ELISA Kit;Human CBTF ELISA Kit;Human MMP4 ELISA Kit;Human NF110 ELISA Kit;Human NF110b ELISA Kit;Human NF90a ELISA Kit;Human NF90b ELISA Kit;Human NFAR-1 ELISA Kit;Human NFAR2 ELISA Kit;Human TCP110 ELISA Kit;Human interleukin enhancer binding factor 3 ELISA Kit;Human interleukin enhancer-binding factor 3 ELISA Kit;Human double-stranded RNA-binding protein, 76 kD ELISA Kit;Human dsRNA binding protein NFAR-2/MPP4 ELISA Kit;Human interleukin enhancer binding factor 3, 90kD ELISA Kit;Human interleukin enhancer binding factor 3, 90kDa ELISA Kit;Human nuclear factor of activated T-cells, 90 kD ELISA Kit;
Catalog
E020812
species
Human
GeneILF3
SpecificityThis assay has high sensitivity and excellent specificity for detection of human ILF3. No significant cross-reactivity or interference between human ILF3 and analogues was observed.
SamplesSerum, Plasma , tissue homogenates,Cell culture supernates,Other biological fluids.
SensitivityThe minimum detectable dose of human ILF3 is typically less than 4.69 pg/ml. The sensitivity of this assay, or Lower Limit of Detection (LLD) was defined as the lowest protein concentration that could be differentiated from zero. It was determined the mea
Intended UseHuman ILF3 ELISA Kit allows for the in vitro quantitative determination of ILF3 , concentrations in serum, Plasma , tissue homogenates and Cell culture supernates and Other biological fluids.
StorageStore the whole ELISA kit at 4℃
Product Description
specificalPrinciple of the Assay: This assay employs the quantitative sandwich enzyme immunoassay technique. Antibody specific for ILF3 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any ILF3 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for ILF3 is added to the wells. After washing, avidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of ILF3 bound in the initial step. The color development is stopped and the intensity of the color is measured.
Human Interleukin enhancer-binding factor 3 Protein information
Uniprot ID ILF3_HUMAN
Uniprot AC Q9UNA2;
UniGene Hs.465885;
GeneID 3609
KEGG hsa:3609;
Human Interleukin enhancer-binding factor 3 Protein SEQUENCE
SEQUENCE 894 AA; 95338 MW; 20903ABD0331F370 CRC64;
MRPMRIFVND DRHVMAKHSS VYPTQEELEA VQNMVSHTER ALKAVSDWID
EQEKGSSEQA ESDNMDVPPE DDSKEGAGEQ KTEHMTRTLR GVMRVGLVAK
GLLLKGDLDL ELVLLCKEKP TTALLDKVAD NLAIQLAAVT EDKYEILQSV
DDAAIVIKNT KEPPLSLTIH LTSPVVREEM EKVLAGETLS VNDPPDVLDR
QKCLAALASL RHAKWFQARA NGLKSCVIVI RVLRDLCTRV PTWGPLRGWP
LELLCEKSIG TANRPMGAGE ALRRVLECLA SGIVMPDGSG IYDPCEKEAT
DAIGHLDRQQ REDITQSAQH ALRLAAFGQL HKVLGMDPLP SKMPKKPKNE
NPVDYTVQIP PSTTYAITPM KRPMEEDGEE KSPSKKKKKI QKKEEKAEPP
QAMNALMRLN QLKPGLQYKL VSQTGPVHAP IFTMSVEVDG NSFEASGPSK
KTAKLHVAVK VLQDMGLPTG AEGRDSSKGE DSAEETEAKP AVVAPAPVVE
AVSTPSAAFP SDATAEQGPI LTKHGKNPVM ELNEKRRGLK YELISETGGS
HDKRFVMEVE VDGQKFQGAG SNKKVAKAYA ALAALEKLFP DTPLALDANK
KKRAPVPVRG GPKFAAKPHN PGFGMGGPMH NEVPPPPNLR GRGRGGSIRG
RGRGRGFGGA NHGGYMNAGA GYGSYGYGGN SATAGYSQFY SNGGHSGNAS
GGGGGGGGGS SGYGSYYQGD NYNSPVPPKH AGKKQPHGGQ QKPSYGSGYQ
SHQGQQQSYN QSPYSNYGPP QGKQKGYNHG QGSYSYSNSY NSPGGGGGSD
YNYESKFNYS GSGGRSGGNS YGSGGASYNP GSHGGYGGGS GGGSSYQGKQ
GGYSQSNYNS PGSGQNYSGP PSSYQSSQGG YGRNADHSMN YQYR
UCSC uc002mpl.3; human. [Q12906-1];

Category

Human ILF3 ELISA Kit